NYSE:ELN - Elan Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Elan Corporation Ltd (Elan), formerly Elan Corporation, plc, is a biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. On February 6, 2013, the Company announced that it has entered into an asset purchase agreement with Biogen Idec to transfer to Biogen Idec all Tysabri IP and other assets related to Tysabri. As of 31 December 2012, there were approximately 72,700

Receive ELN News and Ratings via Email

Sign-up to receive the latest news and ratings for ELN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
Phone+353-1-7094000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Elan (NYSE:ELN) Frequently Asked Questions

What is Elan's stock symbol?

Elan trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELN."

Has Elan been receiving favorable news coverage?

Media stories about ELN stock have trended positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Elan earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the next several days.

What other stocks do shareholders of Elan own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Elan investors own include La Jolla Pharmaceutical (LJPC), Sarepta Therapeutics (SRPT), Blackstone Group (BX), Starbucks (SBUX), MGM Resorts International (MGM), Visa (V), Home Depot (HD), Altaba (AABA), Nokia Oyj (NOK) and Gilead Sciences (GILD).

How do I buy shares of Elan?

Shares of ELN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Elan's official website?

The official website for Elan is http://www.elan.com.

How can I contact Elan?

Elan's mailing address is Treasury Building Grand Canal Street Lower, DUBLIN, 2, Ireland. The biotechnology company can be reached via phone at +353-1-7094000.


MarketBeat Community Rating for Elan (NYSE ELN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  191
MarketBeat's community ratings are surveys of what our community members think about Elan and other stocks. Vote "Outperform" if you believe ELN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel